Envestnet Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $66.9M | Buy |
740,002
+408,409
| +123% | +$34.2M | 0.02% | 739 |
|
|
2026
Q1 | $26.6M | Buy |
331,593
+118,098
| +55% | +$9.74M | 0.01% | 1160 |
|
|
2025
Q4 | $18.2M | Sell |
213,495
-48,092
| -18% | -$3.95M | 0.01% | 1268 |
|
|
2025
Q3 | $20.3M | Sell |
261,587
-78,709
| -23% | -$6.15M | 0.01% | 1266 |
|
|
2025
Q2 | $26.6M | Sell |
340,296
-56,459
| -14% | -$4.21M | 0.01% | 1072 |
|
|
2025
Q1 | $28.8M | Sell |
396,755
-12,080
| -3% | -$865K | 0.01% | 970 |
|
|
2024
Q4 | $30.3M | Sell |
408,835
-92,826
| -19% | -$6.5M | 0.01% | 953 |
|
|
2024
Q3 | $33.1M | Sell |
501,661
-650,729
| -56% | -$47.3M | 0.01% | 917 |
|
|
2024
Q2 | $106M | Sell |
1,152,390
-32,185
| -3% | -$2.85M | 0.04% | 428 |
|
|
2024
Q1 | $113M | Sell |
1,184,575
-56,567
| -5% | -$4.75M | 0.04% | 409 |
|
|
2023
Q4 | $94.6M | Buy |
1,241,142
+80,025
| +7% | +$5.57M | 0.04% | 421 |
|
|
2023
Q3 | $80.4M | Buy |
1,161,117
+116,275
| +11% | +$9.34M | 0.04% | 440 |
|
|
2023
Q2 | $98.6M | Buy |
1,044,842
+18,114
| +2% | +$1.57M | 0.04% | 350 |
|
|
2023
Q1 | $84.9M | Buy |
1,026,728
+52,072
| +5% | +$4.09M | 0.04% | 370 |
|
|
2022
Q4 | $72.7M | Sell |
974,656
-9,437
| -1% | -$727K | 0.04% | 379 |
|
|
2022
Q3 | $81.3M | Buy |
984,093
+8,730
| +0.9% | +$840K | 0.05% | 326 |
|
|
2022
Q2 | $92.7M | Sell |
975,363
-646,060
| -40% | -$66.9M | 0.05% | 303 |
|
|
2022
Q1 | $191M | Buy |
1,621,423
+64,224
| +4% | +$7.2M | 0.1% | 184 |
|
|
2021
Q4 | $202M | Buy |
1,557,199
+76,817
| +5% | +$8.96M | 0.1% | 174 |
|
|
2021
Q3 | $168M | Buy |
1,480,382
+120,051
| +9% | +$13.7M | 0.09% | 194 |
|
|
2021
Q2 | $141M | Sell |
1,360,331
-35,559
| -3% | -$3.35M | 0.08% | 216 |
|
|
2021
Q1 | $117M | Buy |
1,395,890
+181,299
| +15% | +$15.3M | 0.08% | 214 |
|
|
2020
Q4 | $111M | Buy |
1,214,591
+243,191
| +25% | +$20.2M | 0.08% | 186 |
|
|
2020
Q3 | $77.5M | Buy |
971,400
+468,044
| +93% | +$36.5M | 0.07% | 222 |
|
|
2020
Q2 | $34.8M | Buy |
503,356
+8,698
| +2% | +$618K | 0.03% | 364 |
|
|
2020
Q1 | $31.1M | Buy |
494,658
+2,202
| +0.4% | +$159K | 0.04% | 329 |
|
|
2019
Q4 | $38.3M | Buy |
492,456
+6,312
| +1% | +$493K | 0.04% | 325 |
|
|
2019
Q3 | $35.6M | Buy |
486,144
+4,953
| +1% | +$348K | 0.04% | 332 |
|
|
2019
Q2 | $29.6M | Buy |
481,191
+35,745
| +8% | +$2.16M | 0.04% | 343 |
|
|
2019
Q1 | $28.4M | Sell |
445,446
-22,998
| -5% | -$1.31M | 0.04% | 341 |
|
|
2018
Q4 | $23.9M | Buy |
468,444
+384,639
| +459% | +$19.5M | 0.04% | 320 |
|
|
2018
Q3 | $4.86M | Sell |
83,805
-233,421
| -74% | -$11.4M | 0.01% | 428 |
|
|
2018
Q2 | $15.4M | Buy |
317,226
+33,039
| +12% | +$1.54M | 0.04% | 234 |
|
|
2018
Q1 | $13.2M | Sell |
284,187
-314,340
| -53% | -$13.7M | 0.04% | 182 |
|
|
2017
Q4 | $22.5M | Buy |
598,527
+65,787
| +12% | +$2.41M | 0.05% | 212 |
|
|
2017
Q3 | $19.4M | Buy |
532,740
+92,409
| +21% | +$3.52M | 0.05% | 223 |
|
|
2017
Q2 | $17.4M | Buy |
440,331
+127,413
| +41% | +$4.65M | 0.05% | 244 |
|
|
2017
Q1 | $9.81M | Buy |
312,918
+130,140
| +71% | +$4.07M | 0.03% | 367 |
|
|
2016
Q4 | $5.71M | Buy |
182,778
+55,869
| +44% | +$1.81M | 0.02% | 498 |
|
|
2016
Q3 | $5.1M | Sell |
126,909
-16,185
| -11% | -$610K | 0.02% | 576 |
|
|
2016
Q2 | $4.76M | Buy |
143,094
+50,748
| +55% | +$1.74M | 0.02% | 645 |
|
|
2016
Q1 | $2.71M | Sell |
92,346
-14,871
| -14% | -$410K | 0.01% | 846 |
|
|
2015
Q4 | $2.82M | Buy |
107,217
+1,875
| +2% | +$48.7K | 0.01% | 798 |
|
|
2015
Q3 | $2.5M | Buy |
105,342
+16,944
| +19% | +$409K | 0.01% | 855 |
|
|
2015
Q2 | $2.1M | Buy |
88,398
+38,904
| +79% | +$878K | 0.01% | 1027 |
|
|
2015
Q1 | $1.18M | Buy |
49,494
+36,126
| +270% | +$810K | 0.01% | 1221 |
|
|
2014
Q4 | $284K | Buy |
13,368
+8,082
| +153% | +$162K | ﹤0.01% | 892 |
|
|
2014
Q3 | $90K | Buy |
5,286
+5,034
| +1,998% | +$79.5K | ﹤0.01% | 1324 |
|
|
2014
Q2 | $4K | Buy |
+252
| New | +$3.42K | ﹤0.01% | 2349 |
|
|
2014
Q1 | – | Sell |
-1,188
| Closed | -$13K | – | 2575 |
|
|
2013
Q4 | $13K | Sell |
1,188
-90
| -7% | -$1.01K | ﹤0.01% | 1643 |
|
|
2013
Q3 | $15K | Buy |
1,278
+198
| +18% | +$2.32K | ﹤0.01% | 1560 |
|
|
2013
Q2 | $12K | Buy |
+1,080
| New | +$12.8K | ﹤0.01% | 1599 |
|
Other funds holding EW
WT
SAM
BHIA
Envestnet Asset Management's EW Position: Q2 2026 in Review
Envestnet Asset Management increased its Edwards Lifesciences (EW) stake by 123% in Q2 2026, buying an estimated $34.2M and bringing the position to 740,002 shares worth $66.9M. The position accounts for 0.02% of the portfolio, ranked #739.
Envestnet Asset Management first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $202M in Q4 2021. 627 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Envestnet Asset Management held 740,002 shares of Edwards Lifesciences worth $66.9M as of Q2 2026.
- Envestnet Asset Management bought 408,409 Edwards Lifesciences shares in Q2 2026, an estimated $34.2M.
- Edwards Lifesciences made up 0.02% of Envestnet Asset Management's portfolio in Q2 2026, its #739 holding.
- Envestnet Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Envestnet Asset Management's Edwards Lifesciences position peaked at $202M in Q4 2021.
- 627 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.